Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04212013
Title A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

marginal zone B-cell lymphoma



Ibrutinib + Rituximab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.